Skip to main content
. 2017 Jun 20;7:269. doi: 10.3389/fcimb.2017.00269

Figure 9.

Figure 9

Efficacy evaluation of inactive HTNV vaccines by detecting NAb titers with ICW (A,B) The NAb titers of vaccinees without boost (two primary doses, n = 8) were determined by the ICW assay (A) and ELISA (B). (C,D) The NAb titers of vaccinees in the boost group (two primary doses, n = 8) were determined by the ICW assay (C) and ELISA (D). (E) The NAb titers of vaccinees with different vaccination strategies were assessed using the ICW assay. Notably, three individuals exhibited no production of NAbs; the NAb titers of these patients were presented as 1 to calculate the geometric mean value. Data are presented as the geometric mean ± 95% CI. *P < 0.05, **P < 0.01, ***P < 0.001 by Student's t-test.